Clinical Trial Update: The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating intravitreal ranibizumab for diabetic macular edema with center-involved edema and lipid exudates; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: South Coast Retina Center; Carson, McBeath, Boswell, Inc. | Conditions: Diabetic Macular Edema, Hard Lipid Exudates | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-08